Home » Lymphoma » Non-Hodgkin lymphoma » Peripheral T-cell lymphoma

Peripheral T-cell lymphoma

4 minute read

Peripheral T-cell lymphoma is a rare type of non-Hodgkin lymphoma.

About peripheral T-cell lymphoma

Peripheral T-cell lymphoma is a rare type of non-Hodgkin lymphoma. It develops from mature T-cells and accounts for approximately 7% of all non-Hodgkin lymphoma cases.

What are the types of peripheral T-cell lymphoma?

Researchers are classifying new subtypes of peripheral T-cell lymphoma all the time, making understanding of this rare type of non-Hodgkin lymphoma somewhat confusing. Better identification of sub types however, creates a better overall understanding of peripheral T-cell lymphoma, which will eventually lead to a more favourable general prognosis for this complex disease.

  • Subcutaneous panniculitis-like T-cell lymphoma – Extranodal. Rare. Commonly involving nodules under the skin (subcutaneous) which can progress to open inflamed sores.
  • Hepatosplenic (Gamma-Delta) T-cell lymphoma – Extranodal. Systemic (affects whole body). Infiltration of liver, spleen and bone marrow by malignant T-cells. Usually without tumours. Difficult to diagnose.
  • Enteropathy-associated T-cell lymphoma – Extranodal. Very rare. Can occur in some people who have the integrated gluten-sensitive intestinal disease Coeliac Disease, often referred to as simply ‘Coeliacs’.
  • Extranodal NK (natural killer)/T-cell lymphoma, nasal type – Extranodal. Previously referred to as angiocentric lymphoma and is more common in Asia and South America. Frequently occurs in the nose and nasal passages as the name suggests, but can also involve other organs. Has an aggressive course and can cause the serious condition- haemophagocytic syndrome.
  • Angioimmunoblastic T-cell lymphoma – Nodal. One of the most common subtypes of peripheral T-cell lymphoma, accounting for approximately 20% of all T-cell lymphomas. Common symptoms include generalised lymphadenopathy (swollen/enlarged lymph nodes), fever, weight loss and skin rash.
  • Peripheral T-cell lymphoma, not otherwise specified – Nodal and/or Extranodal. Most common subtype of PTCL representing a diverse group of diseases for which evidence is lacking a clearer definition. Extranodal sites which may be involved include the liver, bone marrow, intestinal tract and the skin.

Who does peripheral T-cell lymphoma commonly affect?

Peripheral T-cell lymphoma usually affects people over 60, but it can occur anytime in adulthood. It is slightly more common in men than it is in women.

Causes of peripheral T-cell lymphoma

Whilst the exact cause of peripheral T-cell lymphoma is unknown, it can be associated with the exposure to Epstein-Barr virus (EBV) or to the human T-cell leukaemia virus-1 (HTLV-1). The Epstein-Barr virus is also called human herpes virus 4 (HHV-4), and is one of the most common viruses in humans. Infection with EBV occurs by the oral transfer of saliva.

The HTLV-1 virus is a retrovirus, and is in the same class of virus as the HIV/AIDS virus. It is believed that the HTLV-1 virus is transmitted through sexual contact, exposure to contaminated blood and breastfeeding.

Symptoms of peripheral T-cell lymphoma

Peripheral T-cell lymphoma is a lymphoma of the T-cells (also referred to as T-lymphocytes), a type of white blood cell that play a central role in the immune response of the body. T-cells mature in the thymus (a specialised organ of the immune system which sits in the upper chest region under the breastbone)- which is how they get their name, and circulate within the lymphatic system. Although there are many different sub types of peripheral T-cell lymphoma, they often present in a similar way, being widespread, enlarged, painless lymph nodes in the neck, armpit or groin. Other symptoms may include enlargement of the liver and spleen, night sweats, fever, weight loss and a skin rash.

Treatment of peripheral T-cell lymphoma

Treatment for peripheral T-cell lymphoma aims to cure and includes the use of combination chemotherapy regimens, localised radiotherapy, stem cell transplants and steroid therapy. Just as individuals vary in terms of their medical condition, age and other factors; so too does the exact treatment one will receive for PTCL. It is vital that all treatment options be discussed with your specialist, including the possibility of a clinical trial as initial treatment where appropriate.

Caring for someone with peripheral T-cell lymphoma

We have a range of information and resources that may help when you are caring for someone with peripheral T-cell lymphoma.

Last updated: 7 November 2025

heart shield

How this page exists

The information you’re reading is possible thanks to generous Australians who fundraise, donate, and stand with those facing blood cancer. Their support powers more than research – it brings life-changing resources and guidance to those who need it most. Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.

No anchors found on page.

Get support

Reliable transport help so you can reach vital appointments safely.

Comfortable accommodation close to treatment when home is far.

Practical financial assistance to ease everyday costs during treatment.

Caring emotional support to help you cope and stay strong.

Guidance and programs to maintain strength, nutrition, and mental wellbeing.

Compassionate counselling and resources to navigate loss and healing.

Connect with others who understand through safe online communities.